financetom
Business
financetom
/
Business
/
International General Insurance's Q2 net income rises 3.9%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
International General Insurance's Q2 net income rises 3.9%
Aug 5, 2025 3:14 PM

Overview

* IGI Q2 net income rises 3.9% yr/yr to $34.1 mln

* Core operating income for Q2 misses analyst expectations, impacted by currency movements

* Gross written premiums for Q2 fall 8.6% yr/yr, reflecting competitive market conditions

Outlook

* Company notes increasing competition in certain market areas

* IGI highlights impact of U.S. Dollar weakening on results

* Company emphasizes diversification strategy to manage market cyclicality

Result Drivers

* CURRENCY IMPACT - Currency revaluation of non-U.S. Dollar loss reserves negatively impacted underwriting results

* COMPETITIVE MARKET - Gross written premiums fell due to increased competition in insurance and reinsurance markets

* CAT LOSSES - Catastrophe losses contributed to higher loss ratios, affecting underwriting income

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Core Miss $0.51 $0.53 (2

Operatin Analysts

g EPS )

Q2 EPS $0.77

Q2 Net $34.10

Income mln

Q2 Core Miss $22.80 $26.30

Operatin mln mln (1

g Income Analyst)

Q2 90.5%

Combined

Ratio

Analyst Coverage

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the property & casualty insurance peer group is "buy."

* Wall Street's median 12-month price target for International General Insurance Holdings Ltd ( IGIC ) is $32.00, about 26.7% above its August 4 closing price of $23.47

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Churchill Resources Provides Fall Exploration Program Update For Its Black Raven Property
Churchill Resources Provides Fall Exploration Program Update For Its Black Raven Property
Oct 20, 2025
12:54 PM EDT, 10/20/2025 (MT Newswires) -- Churchill Resources ( CRICF ) on Monday offered an update on its fall exploration program at the Black Raven Property in Newfoundland, which includes the historic Frost Cove Antimony and Stewart Gold mines. The company mobilized a second drill rig on October 14 and by October 18 had completed 16 core holes totaling...
Stellantis CEO calls for softer EU emissions rules as he announces new hiring in Italy
Stellantis CEO calls for softer EU emissions rules as he announces new hiring in Italy
Oct 20, 2025
MILAN, Oct 20 (Reuters) - Stellantis ( STLA ) CEO announced on Monday 400 new hires in Italy and confirmed plans to ramp up output in the country while warning that European Union rules to cut carbon emissions need to be changed to support car production in the region. Antonio Filosa, who met Italian unions in Turin in one of...
Why Is Genmab Stock Trading Lower On Monday?
Why Is Genmab Stock Trading Lower On Monday?
Oct 20, 2025
On Saturday, Genmab A/S ( GMAB ) revealed updated data from cohort B2 of the Phase 1/2 RAINFOL-01 trial evaluating rinatabart sesutecan (Rina-S) in heavily pretreated patients with advanced endometrial cancer. The study showed that at a median study follow-up of one year, treatment with Rina-S 100 mg/m² every 3 weeks (Q3W) resulted in a 50.0% confirmed objective response rate...
Kenvue urges US FDA to reject request for Tylenol's autism warning
Kenvue urges US FDA to reject request for Tylenol's autism warning
Oct 20, 2025
Oct 20 (Reuters) - Kenvue ( KVUE ) has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during pregnancy, after President Donald Trump linked the drug to the condition. A citizen petition filed last month requested changes to the labeling of the drug for use during pregnancy that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved